Report Detail

Pharma & Healthcare Global Cyclin-Dependent Kinase (CDK) Inhibitors Market Research Report 2022

  • RnM4474835
  • |
  • 01 August, 2022
  • |
  • Global
  • |
  • 87 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Highlights
The global Cyclin-Dependent Kinase (CDK) Inhibitors market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

North American market for Cyclin-Dependent Kinase (CDK) Inhibitors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for Cyclin-Dependent Kinase (CDK) Inhibitors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global manufacturers of Cyclin-Dependent Kinase (CDK) Inhibitors include Sanofi, Pfizer Inc., Eli Lilly and Company, Novartis, Astex Pharmaceuticals, Bristol-Myers Squibb Company, Merck KGaA and AstraZeneca, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.

The global market for Cyclin-Dependent Kinase (CDK) Inhibitors in Hospital is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Oral, which accounted for % of the global market of Cyclin-Dependent Kinase (CDK) Inhibitors in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cyclin-Dependent Kinase (CDK) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclin-Dependent Kinase (CDK) Inhibitors.

The Cyclin-Dependent Kinase (CDK) Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cyclin-Dependent Kinase (CDK) Inhibitors market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cyclin-Dependent Kinase (CDK) Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Sanofi

Pfizer Inc.

Eli Lilly and Company

Novartis

Astex Pharmaceuticals

Bristol-Myers Squibb Company

Merck KGaA

AstraZeneca

Product Type Insights

Global markets are presented by Cyclin-Dependent Kinase (CDK) Inhibitors type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Cyclin-Dependent Kinase (CDK) Inhibitors are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Cyclin-Dependent Kinase (CDK) Inhibitors segment by Type

Oral

Intravenous Injection

Others

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Cyclin-Dependent Kinase (CDK) Inhibitors market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Cyclin-Dependent Kinase (CDK) Inhibitors market.

Cyclin-Dependent Kinase (CDK) Inhibitors segment by Application

Hospital

Pharmacy

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Cyclin-Dependent Kinase (CDK) Inhibitors market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclin-Dependent Kinase (CDK) Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Cyclin-Dependent Kinase (CDK) Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Cyclin-Dependent Kinase (CDK) Inhibitors industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclin-Dependent Kinase (CDK) Inhibitors.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Cyclin-Dependent Kinase (CDK) Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Cyclin-Dependent Kinase (CDK) Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Analysis of sales channel, distributors and customers

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.

Chapter 11: The main points and conclusions of the report.


Table of content:

    1 Cyclin-Dependent Kinase (CDK) Inhibitors Market Overview

    • 1.1 Product Overview and Scope of Cyclin-Dependent Kinase (CDK) Inhibitors
    • 1.2 Cyclin-Dependent Kinase (CDK) Inhibitors Segment by Type
    • 1.2.1 Global Cyclin-Dependent Kinase (CDK) Inhibitors Sales Growth Rate Comparison by Type (2022-2028)
  • 1.2.2 Oral
  • 1.2.3 Intravenous Injection
  • 1.2.4 Others
  • 1.3 Cyclin-Dependent Kinase (CDK) Inhibitors Segment by Application
  • 1.3.1 Global Cyclin-Dependent Kinase (CDK) Inhibitors Sales Comparison by Application: (2022-2028)
  • 1.3.2 Hospital
  • 1.3.3 Pharmacy
  • 1.3.4 Others
  • 1.4 Global Cyclin-Dependent Kinase (CDK) Inhibitors Market Size Estimates and Forecasts
  • 1.4.1 Global Cyclin-Dependent Kinase (CDK) Inhibitors Revenue 2017-2028
  • 1.4.2 Global Cyclin-Dependent Kinase (CDK) Inhibitors Sales 2017-2028
  • 1.4.3 Cyclin-Dependent Kinase (CDK) Inhibitors Market Size by Region: 2017 Versus 2021 Versus 2028
  • 2 Cyclin-Dependent Kinase (CDK) Inhibitors Market Competition by Manufacturers

    • 2.1 Global Cyclin-Dependent Kinase (CDK) Inhibitors Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Cyclin-Dependent Kinase (CDK) Inhibitors Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Cyclin-Dependent Kinase (CDK) Inhibitors Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Cyclin-Dependent Kinase (CDK) Inhibitors Manufacturing Sites, Area Served, Product Type
    • 2.5 Cyclin-Dependent Kinase (CDK) Inhibitors Market Competitive Situation and Trends
    • 2.5.1 Cyclin-Dependent Kinase (CDK) Inhibitors Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Cyclin-Dependent Kinase (CDK) Inhibitors Players Market Share by Revenue
  • 2.5.3 Global Cyclin-Dependent Kinase (CDK) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 3 Cyclin-Dependent Kinase (CDK) Inhibitors Retrospective Market Scenario by Region

    • 3.1 Global Cyclin-Dependent Kinase (CDK) Inhibitors Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Cyclin-Dependent Kinase (CDK) Inhibitors Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Cyclin-Dependent Kinase (CDK) Inhibitors Market Facts & Figures by Country
    • 3.3.1 North America Cyclin-Dependent Kinase (CDK) Inhibitors Sales by Country
  • 3.3.2 North America Cyclin-Dependent Kinase (CDK) Inhibitors Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
  • 3.4 Europe Cyclin-Dependent Kinase (CDK) Inhibitors Market Facts & Figures by Country
  • 3.4.1 Europe Cyclin-Dependent Kinase (CDK) Inhibitors Sales by Country
  • 3.4.2 Europe Cyclin-Dependent Kinase (CDK) Inhibitors Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
  • 3.5 Asia Pacific Cyclin-Dependent Kinase (CDK) Inhibitors Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Cyclin-Dependent Kinase (CDK) Inhibitors Sales by Region
  • 3.5.2 Asia Pacific Cyclin-Dependent Kinase (CDK) Inhibitors Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.6 Latin America Cyclin-Dependent Kinase (CDK) Inhibitors Market Facts & Figures by Country
  • 3.6.1 Latin America Cyclin-Dependent Kinase (CDK) Inhibitors Sales by Country
  • 3.6.2 Latin America Cyclin-Dependent Kinase (CDK) Inhibitors Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
  • 3.7 Middle East and Africa Cyclin-Dependent Kinase (CDK) Inhibitors Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Cyclin-Dependent Kinase (CDK) Inhibitors Sales by Country
  • 3.7.2 Middle East and Africa Cyclin-Dependent Kinase (CDK) Inhibitors Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE
  • 4 Global Cyclin-Dependent Kinase (CDK) Inhibitors Historic Market Analysis by Type

    • 4.1 Global Cyclin-Dependent Kinase (CDK) Inhibitors Sales Market Share by Type (2017-2022)
    • 4.2 Global Cyclin-Dependent Kinase (CDK) Inhibitors Revenue Market Share by Type (2017-2022)
    • 4.3 Global Cyclin-Dependent Kinase (CDK) Inhibitors Price by Type (2017-2022)

    5 Global Cyclin-Dependent Kinase (CDK) Inhibitors Historic Market Analysis by Application

    • 5.1 Global Cyclin-Dependent Kinase (CDK) Inhibitors Sales Market Share by Application (2017-2022)
    • 5.2 Global Cyclin-Dependent Kinase (CDK) Inhibitors Revenue Market Share by Application (2017-2022)
    • 5.3 Global Cyclin-Dependent Kinase (CDK) Inhibitors Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Sanofi
    • 6.1.1 Sanofi Corporation Information
  • 6.1.2 Sanofi Description and Business Overview
  • 6.1.3 Sanofi Cyclin-Dependent Kinase (CDK) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 Sanofi Cyclin-Dependent Kinase (CDK) Inhibitors Product Portfolio
  • 6.1.5 Sanofi Recent Developments/Updates
  • 6.2 Pfizer Inc.
  • 6.2.1 Pfizer Inc. Corporation Information
  • 6.2.2 Pfizer Inc. Description and Business Overview
  • 6.2.3 Pfizer Inc. Cyclin-Dependent Kinase (CDK) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 Pfizer Inc. Cyclin-Dependent Kinase (CDK) Inhibitors Product Portfolio
  • 6.2.5 Pfizer Inc. Recent Developments/Updates
  • 6.3 Eli Lilly and Company
  • 6.3.1 Eli Lilly and Company Corporation Information
  • 6.3.2 Eli Lilly and Company Description and Business Overview
  • 6.3.3 Eli Lilly and Company Cyclin-Dependent Kinase (CDK) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 Eli Lilly and Company Cyclin-Dependent Kinase (CDK) Inhibitors Product Portfolio
  • 6.3.5 Eli Lilly and Company Recent Developments/Updates
  • 6.4 Novartis
  • 6.4.1 Novartis Corporation Information
  • 6.4.2 Novartis Description and Business Overview
  • 6.4.3 Novartis Cyclin-Dependent Kinase (CDK) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Novartis Cyclin-Dependent Kinase (CDK) Inhibitors Product Portfolio
  • 6.4.5 Novartis Recent Developments/Updates
  • 6.5 Astex Pharmaceuticals
  • 6.5.1 Astex Pharmaceuticals Corporation Information
  • 6.5.2 Astex Pharmaceuticals Description and Business Overview
  • 6.5.3 Astex Pharmaceuticals Cyclin-Dependent Kinase (CDK) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 Astex Pharmaceuticals Cyclin-Dependent Kinase (CDK) Inhibitors Product Portfolio
  • 6.5.5 Astex Pharmaceuticals Recent Developments/Updates
  • 6.6 Bristol-Myers Squibb Company
  • 6.6.1 Bristol-Myers Squibb Company Corporation Information
  • 6.6.2 Bristol-Myers Squibb Company Description and Business Overview
  • 6.6.3 Bristol-Myers Squibb Company Cyclin-Dependent Kinase (CDK) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 Bristol-Myers Squibb Company Cyclin-Dependent Kinase (CDK) Inhibitors Product Portfolio
  • 6.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
  • 6.7 Merck KGaA
  • 6.6.1 Merck KGaA Corporation Information
  • 6.6.2 Merck KGaA Description and Business Overview
  • 6.6.3 Merck KGaA Cyclin-Dependent Kinase (CDK) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Merck KGaA Cyclin-Dependent Kinase (CDK) Inhibitors Product Portfolio
  • 6.7.5 Merck KGaA Recent Developments/Updates
  • 6.8 AstraZeneca
  • 6.8.1 AstraZeneca Corporation Information
  • 6.8.2 AstraZeneca Description and Business Overview
  • 6.8.3 AstraZeneca Cyclin-Dependent Kinase (CDK) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 AstraZeneca Cyclin-Dependent Kinase (CDK) Inhibitors Product Portfolio
  • 6.8.5 AstraZeneca Recent Developments/Updates
  • 7 Cyclin-Dependent Kinase (CDK) Inhibitors Manufacturing Cost Analysis

    • 7.1 Cyclin-Dependent Kinase (CDK) Inhibitors Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Cyclin-Dependent Kinase (CDK) Inhibitors
  • 7.4 Cyclin-Dependent Kinase (CDK) Inhibitors Industrial Chain Analysis
  • 8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Cyclin-Dependent Kinase (CDK) Inhibitors Distributors List
    • 8.3 Cyclin-Dependent Kinase (CDK) Inhibitors Customers

    9 Cyclin-Dependent Kinase (CDK) Inhibitors Market Dynamics

    • 9.1 Cyclin-Dependent Kinase (CDK) Inhibitors Industry Trends
    • 9.2 Cyclin-Dependent Kinase (CDK) Inhibitors Market Drivers
    • 9.3 Cyclin-Dependent Kinase (CDK) Inhibitors Market Challenges
    • 9.4 Cyclin-Dependent Kinase (CDK) Inhibitors Market Restraints

    10 Global Market Forecast

    • 10.1 Cyclin-Dependent Kinase (CDK) Inhibitors Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Cyclin-Dependent Kinase (CDK) Inhibitors by Type (2023-2028)
  • 10.1.2 Global Forecasted Revenue of Cyclin-Dependent Kinase (CDK) Inhibitors by Type (2023-2028)
  • 10.2 Cyclin-Dependent Kinase (CDK) Inhibitors Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Cyclin-Dependent Kinase (CDK) Inhibitors by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of Cyclin-Dependent Kinase (CDK) Inhibitors by Application (2023-2028)
  • 10.3 Cyclin-Dependent Kinase (CDK) Inhibitors Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Cyclin-Dependent Kinase (CDK) Inhibitors by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of Cyclin-Dependent Kinase (CDK) Inhibitors by Region (2023-2028)
  • 11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
    • 12.3 Author List
    • Summary:
      Get latest Market Research Reports on Cyclin-Dependent Kinase (CDK) Inhibitors. Industry analysis & Market Report on Cyclin-Dependent Kinase (CDK) Inhibitors is a syndicated market report, published as Global Cyclin-Dependent Kinase (CDK) Inhibitors Market Research Report 2022. It is complete Research Study and Industry Analysis of Cyclin-Dependent Kinase (CDK) Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,404.10
      4,808.20
      2,853.60
      5,707.20
      391,500.00
      783,000.00
      229,941.00
      459,882.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report